Illustration: Shutterstock

Biotech’s op­ti­mism is re­turn­ing amid signs of a bet­ter sec­ond half and a brighter 2024

Odysseus even­tu­al­ly made it to shore, as Bridge­Bio CEO Neil Ku­mar re­mind­ed the in­dus­try last Fri­day in a nod to Homer’s clas­sic tale. And …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.